AAA
Affinity Asset Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-258,115
| Closed | -$5.05M | – | 76 |
|
|
2022
Q4 | $5.05M | Sell |
258,115
-9,679
| -4% | -$189K | 1.98% | 16 |
|
|
2022
Q3 | $4.27M | Buy |
267,794
+17,328
| +7% | +$277K | 1.19% | 20 |
|
|
2022
Q2 | $3.45M | Sell |
250,466
-49,534
| -17% | -$682K | 1.45% | 19 |
|
|
2022
Q1 | $4.76M | Buy |
300,000
+135,000
| +82% | +$2.14M | 0.76% | 19 |
|
|
2021
Q4 | $3.6M | Buy |
165,000
+84,772
| +106% | +$1.85M | 1.31% | 28 |
|
|
2021
Q3 | $2.4M | Sell |
80,228
-39,772
| -33% | -$1.19M | 0.61% | 31 |
|
|
2021
Q2 | $5.32M | Buy |
120,000
+35,000
| +41% | +$1.55M | 1.9% | 12 |
|
|
2021
Q1 | $3.77M | Sell |
85,000
-20,000
| -19% | -$887K | 1.28% | 14 |
|
|
2020
Q4 | $5.76M | Buy |
+105,000
| New | +$5.76M | 3.05% | 6 |
|